Inside Modern Biotech

A Vitamin You Can Buy at Any Pharmacy Just Helped Double Chemotherapy Success Rates in Breast Cancer

36 min · 3 de may de 2026
Portada del episodio A Vitamin You Can Buy at Any Pharmacy Just Helped Double Chemotherapy Success Rates in Breast Cancer

Descripción

Researchers in Brazil ran a randomized controlled trial on 80 women undergoing chemotherapy for breast cancer. One group took 2,000 IU of vitamin D daily. The other took a placebo. After six months, 43% of the vitamin D group had no cancer left by the time of surgery. In the placebo group, only 24% did. That is a 79% relative difference. From a supplement that costs a few dollars a month. In this episode, we break down what the study actually found, why the numbers need careful reading, and what a second independent trial from Turkey with 227 patients adds to the picture. We explain what vitamin D actually does inside cancer cells: how it pushes them toward self-destruction, cuts off their blood supply, and may make chemotherapy more effective. We also cover why so many breast cancer patients are deficient before treatment even begins, what dose was used and why it is considered safe, and what needs to happen before this changes standard clinical practice. This is not a story about a miracle supplement. It is a story about a real signal in real data, a biologically plausible mechanism, and what it could mean for patients in health systems where expensive cancer drugs are out of reach. Source: Omodei et al., Nutrition and Cancer, 2025. DOI: 10.1080/01635581.2025.2480854 Supporting: Özkurt et al., World Journal of Surgery, 2025. DOI: 10.1002/wjs.12587

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Inside Modern Biotech!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

6 episodios

episode A Vitamin You Can Buy at Any Pharmacy Just Helped Double Chemotherapy Success Rates in Breast Cancer artwork

A Vitamin You Can Buy at Any Pharmacy Just Helped Double Chemotherapy Success Rates in Breast Cancer

Researchers in Brazil ran a randomized controlled trial on 80 women undergoing chemotherapy for breast cancer. One group took 2,000 IU of vitamin D daily. The other took a placebo. After six months, 43% of the vitamin D group had no cancer left by the time of surgery. In the placebo group, only 24% did. That is a 79% relative difference. From a supplement that costs a few dollars a month. In this episode, we break down what the study actually found, why the numbers need careful reading, and what a second independent trial from Turkey with 227 patients adds to the picture. We explain what vitamin D actually does inside cancer cells: how it pushes them toward self-destruction, cuts off their blood supply, and may make chemotherapy more effective. We also cover why so many breast cancer patients are deficient before treatment even begins, what dose was used and why it is considered safe, and what needs to happen before this changes standard clinical practice. This is not a story about a miracle supplement. It is a story about a real signal in real data, a biologically plausible mechanism, and what it could mean for patients in health systems where expensive cancer drugs are out of reach. Source: Omodei et al., Nutrition and Cancer, 2025. DOI: 10.1080/01635581.2025.2480854 Supporting: Özkurt et al., World Journal of Surgery, 2025. DOI: 10.1002/wjs.12587

3 de may de 202636 min
episode The Fossil That Waited 150 Million Years to Answer Darwin’s Question artwork

The Fossil That Waited 150 Million Years to Answer Darwin’s Question

In 1859, Darwin predicted the fossil record would reveal creatures caught mid-evolution. Two years later, workers in a German quarry found one: feathers of a bird, teeth of a lizard. They called it Archaeopteryx. For 164 years, one question stayed unanswered: could it actually fly? In this episode, we walk through the Chicago Archaeopteryx — the 14th and smallest known specimen, acquired by the Field Museum in 2022, still encased in rock. After 1,300 hours of preparation using UV light and CT scanning, what emerged was unlike anything seen in 160 years of study. We cover the soft tissue glowing under UV. The tertial feathers that finally settled the flight debate. What the roof of the mouth tells us about how rigid dinosaur skulls became the nimble, kinetic structures of modern birds. And the finding hiding beneath it all: flight may have evolved not once, but multiple times across the dinosaur family tree. A 150-million-year-old animal. A 165-year argument. The moment science finally got a good enough look to settle it. Source: O’Connor et al., Nature, May 2025. DOI: 10.1038/s41586-025-08912-4

3 de may de 202651 min